{"administration site erythema": 2.32, "administration site swelling": 20.44, "adnexa uteri pain": 9.29, "amenorrhoea": 5.34, "axillary pain": 5.09, "breast pain": 3.43, "catarrh": 2.97, "cervicobrachial syndrome": 6.26, "chillblains": 5.12, "covid-19 immunisation": 11.32, "covid-19 pneumonia": 2.46, "deafness unilateral": 2.24, "dysmenorrhoea": 6.03, "endometriosis": 3.27, "erythema nodosum": 2.2, "facial paralysis": 2.34, "formication": 3.95, "headache": 2.0, "heavy menstrual bleeding": 4.17, "hemiparaesthesia": 3.44, "immunisation reaction": 24.1, "increased viscosity of upper respiratory secretion": 12.54, "influenza like illness": 4.29, "injection site erythema": 2.99, "injection site joint erythema": 27.36, "injection site joint swelling": 55.45, "injection site oedema": 2.25, "injection site paraesthesia": 4.71, "injection site rash": 4.85, "injection site urticaria": 4.32, "intermenstrual bleeding": 4.65, "lymphadenitis": 5.08, "lymphadenopathy": 5.06, "malaise": 3.39, "mastitis": 2.43, "mechanical urticaria": 5.24, "menometrorrhagia": 15.94, "menstrual disorder": 3.63, "menstruation delayed": 3.72, "menstruation irregular": 4.55, "muscle contractions involuntary": 2.07, "myalgia": 2.65, "myocarditis": 2.18, "myopericarditis": 5.41, "neuralgic amyotrophy": 4.41, "nuchal rigidity": 3.74, "odynophagia": 8.38, "oligomenorrhoea": 6.77, "oral herpes": 2.58, "paraesthesia": 2.02, "pelvic pain": 3.96, "periarthritis": 2.15, "pericarditis": 2.55, "polymenorrhoea": 4.42, "polymyalgia rheumatica": 2.5, "premenstrual pain": 3.24, "premenstrual syndrome": 11.77, "pyrexia": 4.59, "skin reaction": 2.84, "temperature regulation disorder": 30.04, "tinnitus": 2.67, "urticaria chronic": 2.48, "uterine haemorrhage": 4.62, "uterine pain": 6.55, "vaccination site cellulitis": 10.43, "vaccination site discomfort": 4.09, "vaccination site eczema": 14.49, "vaccination site erythema": 4.44, "vaccination site haematoma": 10.46, "vaccination site induration": 11.19, "vaccination site inflammation": 86.93, "vaccination site joint erythema": 39.3, "vaccination site joint pain": 5.87, "vaccination site lymphadenopathy": 33.06, "vaccination site mass": 8.56, "vaccination site movement impairment": 5.99, "vaccination site oedema": 10.2, "vaccination site pain": 7.6, "vaccination site paraesthesia": 10.75, "vaccination site pruritus": 7.52, "vaccination site rash": 23.88, "vaccination site reaction": 10.23, "vaccination site swelling": 2.35, "vaccination site urticaria": 14.52, "vaccination site warmth": 7.08, "vestibular neuronitis": 2.59}